Skip to content
10-K

Annual Report

REMEDENT, INC.

0001104659-20-078053

← back to feed
Filed
Jun 29, 2020 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Jun 29, 2020 20M sh
Shares Diluted FY 2020 · Mar 31, 2020 20M sh
Shares Diluted FY 2020 · Mar 31, 2019 20M sh
Operating Cash Flow FY 2020 · Mar 31, 2020 $101.55K
Operating Cash Flow FY 2020 · Mar 31, 2019 $567.62K
Cash And Equivalents FY 2020 · Mar 31, 2020 $114.63K
Cash And Equivalents FY 2020 · Mar 31, 2019 $66.54K
Stockholders Equity FY 2020 · Mar 31, 2020 $4.55M
Stockholders Equity FY 2020 · Mar 31, 2019 $5.39M
Current Liabilities FY 2020 · Mar 31, 2020 $2.88M
Current Liabilities FY 2020 · Mar 31, 2019 $2.43M
Total Liabilities FY 2020 · Mar 31, 2020 $2.89M
Total Liabilities FY 2020 · Mar 31, 2019 $2.43M
Current Assets FY 2020 · Mar 31, 2020 $681.06K
Current Assets FY 2020 · Mar 31, 2019 $655.93K
Total Assets FY 2020 · Mar 31, 2020 $7.51M
Total Assets FY 2020 · Mar 31, 2019 $7.9M
Eps Diluted FY 2020 · Mar 31, 2020 −$0.04
Eps Diluted restated FY 2020 · Mar 31, 2019 $0.11
Eps Basic FY 2020 · Mar 31, 2020 −$0.04
Eps Basic restated FY 2020 · Mar 31, 2019 $0.11
Sga Expense FY 2020 · Mar 31, 2020 $748.86K
Sga Expense FY 2020 · Mar 31, 2019 $1.01M
Net Income FY 2020 · Mar 31, 2020 −$858.22K
Net Income FY 2020 · Mar 31, 2019 $2.13M
Operating Income FY 2020 · Mar 31, 2020 −$479.61K
Operating Income FY 2020 · Mar 31, 2019 −$717.35K
Gross Profit FY 2020 · Mar 31, 2020 $742.17K
Gross Profit FY 2020 · Mar 31, 2019 $1.12M
Cost Of Revenue FY 2020 · Mar 31, 2020 $322.25K
Cost Of Revenue FY 2020 · Mar 31, 2019 $486.5K
Revenue FY 2020 · Mar 31, 2020 $1.06M
Revenue FY 2020 · Mar 31, 2019 $1.6M
Rd Expense FY 2020 · Mar 31, 2019 $120